10X Fund, L.P. sold $204k of GALT
owner at GALECTIN THERAPEUTICS INC. 30,681 shares at an average of $6.66, traded Dec 16, 2025, filed Dec 18, 2025.
Score components
- +12Role10% owner
- +12Trade size$204k at market
- 0Share of holdings soldSold 0.5% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -50.6%, 3m -54.5%, 6m -54.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-028303, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | JOther Common Stock | -24,000 | - | - | 5,645,138 | Dec 18, 2025 |
| Dec 16, 2025 | SOpen-market sale Common Stock | -30,681 | $6.66 | $204k | 5,614,457 | Dec 18, 2025 |
Related signals
Other insiders at GALECTIN THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 9Weak | GALECTIN THERAPEUTICS INC | Khurram Jamil Chief Medical Officer | $83k 16,250 shares | -100% | |
| 21Weak | GALECTIN THERAPEUTICS INC | Khurram Jamil Chief Medical Officer | $262k 52,037 shares | -2555% | |
| 19Weak | GALECTIN THERAPEUTICS INC | Harold H. Shlevin director | $151k 30,000 shares | -211% | |
| 8Weak | GALECTIN THERAPEUTICS INC | Khurram Jamil Chief Medical Officer | $24k 7,557 shares | -100% | |
| 0Weak | GALECTIN THERAPEUTICS INC | Khurram Jamil Chief Medical Officer | $1,761 568 shares | -100% | |
| 23Weak | GALTbuy GALECTIN THERAPEUTICS INC | Kary Eldred director | $810 300 shares | +0% | |
| 35Weak | GALECTIN THERAPEUTICS INC | Jack W Callicutt Chief Financial Officer | $233k 60,000 shares | -89% | |
| 28Weak | GALECTIN THERAPEUTICS INC | Khurram Jamil Chief Medical Officer | $232k 60,000 shares | -100% | |
| 19Weak | GALECTIN THERAPEUTICS INC | Joel Lewis President and CEO | $321k 84,000 shares | -9% | |
| 21Weak | GALECTIN THERAPEUTICS INC | Khurram Jamil Chief Medical Officer | $33k 8,125 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.